Description

Mastebolin is a therapeutic preparation primarily indicated for the treatment of breast cancer in elderly post-menopausal women, particularly in cases where the disease is hormone-dependent. It is often used as part of a specific immunotherapy regimen designed to help manage the progression of cancer by modifying the hormonal environment that supports tumor growth.
In post-menopausal women, hormonal imbalances can contribute to the development and spread of certain types of breast cancer. Mastebolin works by exerting an anti-estrogenic effect, thereby reducing the influence of estrogen on cancer cells and helping to slow or inhibit their proliferation.
By balancing hormone activity and enhancing the body’s natural defense mechanisms, Mastebolin plays a supportive role in comprehensive cancer therapy. It may also aid in improving strength and overall well-being during long-term treatment. The medication should be administered strictly under medical supervision, with dosage and duration determined according to the patient’s specific health condition and therapeutic response.